The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Novartis
Speakers' Bureau - Janssen-Ortho
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Novartis
KEYNOTE-185: a randomized, open-label phase 3 study of pembrolizumab in combination with lenalidomide and low-dose dexamethasone in newly diagnosed and treatment-naive multiple myeloma (MM).
 
Antonio Palumbo
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Novartis; Onyx; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Onyx
 
María-Victoria Mateos
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Celgene; Janssen
 
Jesus San Miguel
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Millennium; MSD; Novartis; Onyx
 
Jatin Shah
Consulting or Advisory Role - Lilly
Research Funding - Berg Pharma (Inst); Boston Biomedical (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst)
 
Seth Thompson
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Research Funding - Agensys; Merck
Travel, Accommodations, Expenses - Amgen
 
Patricia Maria Marinello
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Sundar Jagannath
No Relationships to Disclose